Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Chinese Patent Office
Covington
Dow
Teva
Accenture
Moodys
AstraZeneca
Cerilliant

Generated: January 19, 2018

DrugPatentWatch Database Preview

Photocure Asa Company Profile

« Back to Dashboard

What is the competitive landscape for PHOTOCURE ASA, and when can generic versions of PHOTOCURE ASA drugs launch?

PHOTOCURE ASA has one approved drug.

There are two US patents protecting PHOTOCURE ASA drugs.

There are forty patent family members on PHOTOCURE ASA drugs in twenty countries and nine supplementary protection certificates in five countries.

Summary for Photocure Asa
International Patents:40
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Photocure Asa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Photocure Asa

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Subscribe ➤ Subscribe
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Subscribe ➤ Subscribe
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Photocure Asa

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,287,646 Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy ➤ Subscribe
6,034,267 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy ➤ Subscribe
8,410,172 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy ➤ Subscribe
6,492,420 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy ➤ Subscribe
7,335,684 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy ➤ Subscribe
7,247,655 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy ➤ Subscribe
6,992,107 Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy ➤ Subscribe
7,850,008 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Photocure Asa Drugs

Supplementary Protection Certificates for Photocure Asa Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0207 Netherlands ➤ Subscribe 300207, 20160308, EXPIRES: 20190916
C/GB02/038 United Kingdom ➤ Subscribe PRODUCT NAME: METHYL AMINOLEVULINATE, OPTIONALLY IN THE FORM OF A SALT, PREFERABLY METHYL AMINOLEVULINATE HYDROCHLORIDE; REGISTERED: SE 16338 20010615; UK PL18952/0002 20020408
C0042 France ➤ Subscribe PRODUCT NAME: HEXYL AMINOLEVULINATE; NAT. REGISTRATION NO/DATE: NL 30979 20050812; FIRST REGISTRATION: SE - 19 227 20040917
C/GB05/044 United Kingdom ➤ Subscribe PRODUCT NAME: HEXYL AMINOLEVULINATE, OPTIONALLY IN THE FORM OF A SALT, PREFERABLY HEXYL AMINOLEVULINATE HYDROCHLORIDE; REGISTERED: SE 19227 20040917; UK PL 18952/0003 20050714
C019/2008 Ireland ➤ Subscribe SPC019/2008: 20090219, EXPIRES: 20190916
C024/2002 Ireland ➤ Subscribe SPC024/2002: 20041230, EXPIRES: 20160614
0820432/02 Switzerland ➤ Subscribe FORMER REPRESENTATIVE: BOHEST AG, CH
0176 Netherlands ➤ Subscribe 300176, 20160308, EXPIRES: 20160614
C0010 France ➤ Subscribe PRODUCT NAME: AMINOLEVULINATE DE METHYLE CHLORHYDRATE; NAT. REGISTRATION NO/DATE: NL 30885 20060919; FIRST REGISTRATION: SE - 16338 20010615
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Fish and Richardson
Federal Trade Commission
Accenture
Dow
Novartis
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot